TSCAN THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
TSCAN THERAPEUTICS, INC. (TCRX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $12.96 million as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-04
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $12.96M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $10.09M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $9.51M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $9.03M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $12.96M 10-K · filed 2026-03-04 |
| 2024-12-31 | $10.09M 10-K · filed 2025-03-05 |
| 2023-12-31 | $9.51M 10-K · filed 2024-03-06 |
| 2022-12-31 | $9.03M 10-K · filed 2023-03-08 |
| 2021-12-31 | $2.08M 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |